The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Cognitive Impairment: Dementia and Alzheimer's Disease
Abstract
The importance of dementia, a syndrome of global cognitive impairment, has gained widespread recognition in the past two decades. The most common cause, Alzheimer's disease, may be the single greatest source of dysfunction among persons over age 85. The disease, distinct from normal aging, is progressive, has a highly variable course, and can have tremendous impact on families. Duration of symptoms averages eight to ten years from onset, four to five years from diagnosis. Diagnosis is often delayed, because of the insidious nature of the illness. Prevalence and incidence rates may vary severalfold between different studies. One consistent finding is the dramatic increase with age; prevalence rates are 25-48% for persons over age 85. The two most consistent risk factors for AD are age and positive family history. Another likely risk factor is head trauma. Alzheimer's disease is almost certainly due to heterogeneous causes. Biologic understanding of AD is primarily based on study of distinctive pathologic changes in the brain. Increasingly well-characterized pathologic changes precede the clinical manifestation of disease. Ultimately, the pathologic cause of AD is loss of neurons and neuronal connections in the brain, especially in the frontal and parietal association neocortex. Many systems are involved, but the most affected system is the cholinergic system, followed by the noradrenergic and serotonergic neurotransmitter systems. Drug treatment and other intervention strategies to prevent or delay progression of the disease have been limited, primarily because so little is known about the cause or risk factors for the disease. Current palliative treatments are attempts to minimize the morbidity of abnormal behaviors and medical complications associated with dementia. Ideally, treatment would either involve replacement therapy or drugs, which prevent or delay the pathologic changes that occur in AD. Two of the more promising experimental therapeutic attempts involve interruption of the pathogenetic events involving beta-amyloid and its precursor proteins and administration of NGF. Public health attempts at risk factor reduction are clearly premature. The next decade or two will likely witness improved understanding of the pathogenesis of Alzheimer's disease. Epidemiologic study will contribute to our knowledge of pathogenesis and may reveal heretofore unrecognized and, hopefully, modifiable risk factors. Social and clinical strategies to deal with a disease of such immense importance also needs development and evaluation. The public's interest in this disease is intense, and it looks to the scientific community for progress in understanding and managing this often tragic illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
The occult aftermath of boxing.
Roberts, G. W., Allsop, D., & Bruton, C. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.5.373 · Cited by 518
Cited by
Social Disengagement and Incident Cognitive Decline in Community-Dwelling Elderly Persons
Bassuk, S. S., Glass, T. A., & Berkman, L. F. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-3-199908030-00002 · Cited by 991
Neuropsychological Assessment of Dementia
Salmon, D. P., & Bondi, M. W. (2009) · Annual Review of Psychology · doi:10.1146/annurev.psych.57.102904.190024 · Cited by 442
Depressive Symptomatology and Incident Cognitive Decline in an Elderly Community Sample
Bassuk, S. S., Berkman, L. F., & Wypij, D. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1073 · Cited by 263
Drug-Induced Cognition Disorders in the Elderly: Incidence, Prevention and Management
Gray, S. L., Lai, K. V., & Larson, E. B. (1999) · Drug Safety · doi:10.2165/00002018-199921020-00004 · Cited by 190
Self-citationGenetic Determinants of Human Health Span and Life Span: Progress and New Opportunities
Martin, G. M., Bergman, A., & Barzilai, N. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030125 · Cited by 120
Metadata
- Authors
- Larson, E. B., Kukull, W. A., & Katzman, R. L.
- Venue
- Annual Review of Public Health
- Publisher
- Annual Reviews
- Published
- 1992-05
- Volume
- 13
- Issue
- 1
- Pages
- 431-449
- ISSN
- 0163-7525 (ISSN-L)
- 1545-2093
- OpenAlex
- W2147840193
- Cited by
- 192
- References
- 4
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cognitive Impairment: Dementia and Alzheimer's Disease. https://app.cochat.ai/papers/10.1146/annurev.pu.13.050192.002243
- The paper
- Larson, E. B., Kukull, W. A., & Katzman, R. L. (1992). Cognitive Impairment: Dementia and Alzheimer's Disease. Annual Review of Public Health. https://doi.org/10.1146/annurev.pu.13.050192.002243
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.